HemaSphere
(Jun 2022)
P1211: CLINICAL HETEROGENEITY OF HIGH-GRADE B-CELL LYMPHOMA. EDGE OF TRANSFORMATION.
- A. Misyurina,
- S. Kravchenko,
- A. Magomedova,
- A. Kovrigina,
- T. Obukhova,
- K. Sychevskaya,
- E. Zakharko,
- E. Rubkina,
- V. Misyurin,
- F. Babaeva
Affiliations
- A. Misyurina
- 1 Intensive high-dose chemotherapy of hemablastosis
- S. Kravchenko
- 1 Intensive high-dose chemotherapy of hemablastosis
- A. Magomedova
- 1 Intensive high-dose chemotherapy of hemablastosis
- A. Kovrigina
- 2 Pathology department
- T. Obukhova
- 3 Laboratory of cariology
- K. Sychevskaya
- 1 Intensive high-dose chemotherapy of hemablastosis
- E. Zakharko
- 4 Flow cytometry laboratory, National Research Center for Hematology
- E. Rubkina
- 4 Flow cytometry laboratory, National Research Center for Hematology
- V. Misyurin
- 5 Laboratory of experimental biotherapy of tumors, “N.N. Blokhin National Medical Cancer Research Center”, Moscow, Russia
- F. Babaeva
- 1 Intensive high-dose chemotherapy of hemablastosis
- DOI
-
https://doi.org/10.1097/01.HS9.0000847708.51426.88
- Journal volume & issue
-
Vol. 6
pp.
1097
– 1098
WeChat QR code